Proteomic Characterization of Human Gut Habitual <i>Bacteroides intestinalis</i> against Common Intestinal Bile Acid Stress

Sun, Zeyu; Wang, Yu; Su, Xiaoling; Yang, Xue; Luo, Qixia

doi:https://doi.org/10.1155/2023/8395946

Advanced Gut & Microbiome Research

On this page

Abstract Introduction Materials and Methods Results Discussion Conclusion Data Availability Conflicts of Interest Acknowledgments Supplementary Materials References Copyright Related Articles

Research Article | Open Access

Volume 2023 | Article ID 8395946 | https://doi.org/10.1155/2023/8395946

Proteomic Characterization of Human Gut Habitual Bacteroides intestinalis against Common Intestinal Bile Acid Stress

Zeyu Sun,^1,2Yu Wang,²Xiaoling Su,²Xue Yang,³and Qixia Luo^1,2

Academic Editor: Qixiao Zhai

Received10 Jan 2023

Revised24 Mar 2023

Accepted04 Apr 2023

Published23 May 2023

Abstract

Bacteroides intestinalis (B. intestinalis) is an abundant gastrointestinal commensal bacterium and is able to produce secondary bile acids (BAs) among other important metabolic functions. However, deoxycholic acid (DCA) is known to suppress Bacteroides, suggesting differential molecular impact of different BA species on Bacteroides. Among major human gastrointestinal BA components, we first demonstrated that DCA and chenodeoxycholic acid (CDCA) and their taurine-conjugated species at 1 mM showed significantly higher inhibitory effects on the growth of B. intestinalis than cholic acid (CA) and lithocholic acid (LCA) and their taurine-conjugated species. Then, high-throughput proteomic strategy was used to show that both TCDCA and TDCA caused more proteome-wide modulation than TCA and TLCA. In response to incremental BA toxicity, the main functional changes of B. intestinalis include enhanced protein synthesis, DNA integrity maintenance, and suppressed central metabolic activities. Importantly, key energy and BA metabolism enzymes of B. intestinalis were inhibited by TCDCA and TDCA. These findings provide a basis for future studies to explore how Bacteroides respond to bile stress and how BA composition modulate gut microbiome homeostasis.

1. Introduction

Bile acids (BAs) are steroid acids found predominantly in vertebrates. There are four major BAs, i.e., cholic acid (CA), lithocholic acid (LCA), deoxycholic acid (DCA), and chenodeoxycholic acid (CDCA), in human gastrointestinal (GI) lumen [1, 2]. These BAs are conjugated with taurine or glycine in the liver and secreted to the small intestine where they play important roles in digestion by acting as detergents. Many indigenous GI microorganisms can enzymatically deconjugate BAs and further bioconvert them to secondary BAs before being absorbed back to the host via GI mucosa. Although it has been 40 years since the discovery of enterohepatic cycling metabolism of BAs, the list of secondary BA metabolites and BA-converting gut microbial species is still growing, and our understanding about such a large family of BA components is still incomplete.

The differential impact of BA species on a multitude aspects of host metabolism has been widely explored [3–5]. On the other hand, BAs also exhibit bactericidal activities and therefore are key modulators of gut microbial homeostasis. Unfortunately, our understanding of influence by individual BA on major gut communal bacteria is still incomplete.

One of the most common residents of GI lumen is Bacteroides. Together with Firmicutes, they make up more than 90% of the total gut indigenous microbiota [6]. The Bacteroides is conserved evolutionally among mammalian species, implicating a beneficial symbiotic relationship that was not thoroughly investigated so far. The metabolic influence of Bacteroides on host has been shown in recent studies elaborating their connection to obesity and metabolic syndromes [7–10]. Bacteroides intestinalis (hereafter B. intestinalis) is a highly abundant member of this family that shows ability to ferment dietary fibers and produce short-chain fatty acids (SCFAs) which are key nutrients for colonic epithelium cells [11–14]. Like many other GI bacteria, B. intestinalis also produces polycationic amines including spermidine, spermine, and putrescine which play a variety of critical biological roles including maintenance of mucosal homeostasis [15, 16] and maintenance of DNA and protein stability in host cells [17] and thus was thought to render anticarcinogenic and anti-inflammatory properties [18–20].

It is worthy to note that Bacteroides, the vast majority of them express bile salt hydrolase (BSH) and 7a-hydroxysteroid dehydrogenase (7a-HSDH), are key contributors to the hydrolysis of conjugated BAs and generation of secondary BAs [3, 21–23]. Interestingly, unlike other GI bacteria that convert cholic acid CA and CDCA into DCA and LCA, which are known carcinogens in the human GI tract [24], Bacteroides instead produce 7-oxo derivatives of DCA and LCA which can be later converted to ursodeoxycholic acid, 7-ketolithocholic acid, or 7-epi-cholic acid, thus contributing to the GI health [3, 21, 23]. On the other hand, Bacteroides is influenced by a multitude of host and microenvironmental factors, including the intestinal BA composition. The previous report showed that Bacteroides can be inhibited by DCA [25] produced by other major BA bioconvertors such as Clostridium and Eubacterium [26].

Given that the composition of intestinal BAs varies individually and each BA species has distinct chemical properties and biological activities, it is eligible to propose that differential BA formula contributes to both constitutional and functional diversities of gut microbiota. To understand such complex relationship, it is important to explore the molecular response of gut bacteria against BA insults. To our best knowledge, it is till recently that the differential impact of BA components on gut microbial species starts to draw attention [4]. In addition, little is known regarding the molecular effect of BAs on Bacteroides species. Here in this study, we employed the high-throughput proteomic technology to explore the differential impact of two major primary BA species, cholic acid (CA) and chenodeoxycholic acid (CDCA), and their microbiota-transformed species, deoxycholic acid (DCA) and lithocholic acid (LCA), on one of the major gut habitual member, B. intestinalis. Our investigation showed that both CDCA, TCDCA, DCA, and TDCA inhibit the growth of B. intestinalis substantially. Each BA species exerts their influence on the B. intestinalis proteome in a unique pattern; no protein was found up- or downregulated across all BA-treated samples as compared to controls, while TCDCA and TDCA offer the most significant impacts on multiple functional groups.

2. Materials and Methods

2.1. B. intestinalis Culture Conditions and BA Stimuli

Frozen stocks of B. intestinalis (DSM17393, DSMZ, Germany) were reactivated in modified DSMZ Medium 104 (per liter contained trypticase peptone 5 g, peptone 5 g, yeast extract 10 g, beef extract 5 g, glucose 5 g, K₂HPO₄ 2 g, Tween 80 1 mL, cysteine-HCl 0.5 g, ATCC trace mineral supplement 10 mL, haemin 5 mg, vitamin K1 1 μL, and pH 7.2) and incubated overnight at 37°C in an anaerobic cabinet (Electrotek Anaerobic Workstation, Shipley BD18 4EW, United Kingdom) filled with 10% H₂, 10% CO₂, and 80% N₂. For growth with BA, the medium was supplemented with each of the following BA species at physiologically relevant concentration (1 mM) [27], CA, CDCA, DCA, and LCA, or their taurine-conjugated form: taurocholic acid (TCA), taurochenodeoxycholic acid (TCDCA), taurodeoxycholic acid (TDCA), and taurolithocholic acid (TLCA). All chemicals were acquired from Sigma (MO, USA) unless specified.

2.2. Growth Curve and Colony Counts

Fresh medium was inoculated with log phase culture grown from a single colony by 1 : 100 dilution, and growth curve under anaerobic conditions was determined by recording the optical density of cultures at 600 nm (OD₆₀₀) over 80 hrs. Mid-log-phase (~0.3 of OD₆₀₀, unless mentioned otherwise) cells were diluted 100-fold, spread onto plates (medium with 1.5% agar), and incubated overnight, and colonies were counted. For cultures with BAs, colony counts were recorded after 3 days.

2.3. BA Stimulus and Sample Preparation for Proteomic Study

For proteomic comparison regarding different BA stimuli, B. intestinalis grew in BA-free medium into log phase (), which were then evenly divided and incubated with 1 mM either TCA, TCDCA, TDCA, or TLCA for 2-hour stimulation. Bacterium cultures were then centrifuged at for 15 min at 4°C and washed by 10 mL precooled PBS twice. The overall proteomic workflow is summarized in Figure 1. Briefly, the pellets were then heated in boiling water for 10 min and immediately incubated in -80°C for 1 h before protein extraction by 1 mL 7 M urea, 2% SDS, and 15 mM dithiothreitol. The cell lysate was sonicated for 5 min in ice bath. Protein concentration was determined by RC-DC kit (Bio-Rad). Before tryptic digestion, proteins (200 μg) in lysis buffer were applied to a 10 kDa MWCO spin filter (Millipore) for ultrafiltration and washed by 200 μL 8 M urea. Protein was then alkylated in the dark with 100 μL 30 mM iodoacetamide for 45 min, followed by wash steps using 200 μL 8 M urea once and 200 μL 50 mM triethylammonium bicarbonate (TEAB) twice. Protein was then digested with 4 μg trypsin (Promega, WI) in 200 μL 50 mM TEAB buffer for 16 hrs at 37°C. Postdigestion peptides were collected by ultrafiltration. All ultrafiltration steps were carried out at for 15 min.

2.4. iTRAQ Multiplexing and Peptide Fractionation

Peptides (50 μg) were labeled according to the manufacturer’s 8-plex iTRAQ protocol (Sigma). Two separate isobaric 8-plex iTRAQ reagent sets were used to accommodate 3 replicates for TCA-, TCDCA-, TDCA-, and TLCA-treated samples plus 3 normal controls (N) using the design summarized in Figure 1. Briefly, N1, TCA1, TCDCA1, TDCA1, TLCA1, N3, and TCA3 were tagged by 113, 114, 115, 116, 117, 118, and 119 labels in the iTRAQ run A, while N2, TCA2, TCDCA2, TDCA2, TLCA2, TCDCA3, and TLCA3 were tagged by 113, 114, 115, 116, 117, 118, and 119 labels in the iTRAQ run B. TDCA3 tagged by 121 label was used in both runs as run-to-run reference.

The iTRAQ-multiplexed peptides were first separated on a 1260 HPLC System (Agilent) equipped with an Acquity Peptide BEH C18 column (1.7 μm, 130 Å, and , Waters) kept at 45°C. Mobile phase A contains 0.1% NH₄OH and B contains 0.1% NH₄OH in ACN. The 45 min solvent gradient at a flow rate of 0.2 mL/min was set as follows: 5% B within 2 min, 5–18% B in 25 min, 18–32% B in 13 min, and 32−95% B in 1 min, maintained at 95% B for 4 min. Eluted peptides were monitored by UV at 280 nm. Forty fractions were collected every 1 min from 3 to 42 min, were combined into 20 fractions via a concatenated fashion, and then were dried by SpeedVac. Dried peptides were resuspended in 10 μL 0.1% FA in 2% ACN for nanoLC-MS/MS analysis.

2.5. Mass Spectrometric Acquisition

Peptides (~500 ng) were loaded and enriched on a Symmetry C18 nanoACQUITY Trap Column (100 Å, 5 μm, and ) on a nanoACQUITY UPLC system (Waters, Milford, MA). Peptide separation was performed by a BEH C18 nanoACQUITY Column (130 Å, 1.7 μm, and ) with a 120 min gradient with flow rate set at 200 nL/min. Mobile phase A contains 0.1% FA in water and B contains 0.1% FA in ACN.

Eluted peptides were analyzed by Quadrupole-Orbitrap mass spectrometry (Q Exactive, Thermo). The nanospray source was charged at 1.8 kV. The MS was operated in data-dependent acquisition mode scheduling a MS¹ full survey scan at the 70,000 FWHM resolution (at m/z 200 Th) with automatic gain control (AGC) set to 3e6, followed by 20 MS² scans of precursor ions fragmented by higher-energy collision dissociation with normalized collision energy set to 27%. All MS² spectra were acquired at 17,500 FWHM resolution with AGC set to 2e5. Dynamic exclusion was set to 30 sec.

2.6. Proteomic and iTRAQ Data Analysis

Proteomic data were processed according to the previous method [28]. The acquired mass spectrometry data were searched first against the B. intestinalis DSM 17393 UniProt database (ID: UP000004596) supplemented with common contamination sequences using MaxQuant (version 1.6.0.13). The search was performed under the MS2 report ion quantitation (iTRAQ 8plex) mode. Trypsin was set as protease with up to two missed cleavages. The main database search was performed with mass tolerance of 7 ppm. Oxidation on methionine and carbamidomethylation on cysteine were set as variable and fixed modifications, respectively. The search result was filtered by 1% FDR at protein.

For quantitative analysis, only protein IDs with at least two peptide hits and commonly identified in both iTRAQ runs were used. The iTRAQ report ion intensities of each protein were first normalized against the reference ion intensity of 121 label in both runs A and B to correct run-to-run variations. For each sample, relative protein intensities were normalized against the median value to correct label-to-label variations. Differentially expressed proteins (DEPs) were generated based on log2 fold change or ≤-1, and Student’s -test was .

2.7. Functional Enrichment Analysis

Clusters of DEPs were derived by -means algorithm based on their similarities of expression profile across all samples. Clusters of interested B. intestinalis DEP were then annotated by KEGG GENES based on sequence homology via BlastKOALA service [29] provided by KEGG (http://www.kegg.jp).

3. Results

3.1. Inhibitory Effect of Different Bile Acids on Growth of B. intestinalis

To investigate the effects of different BAs to B. intestinalis, the growth curves with medium supplemented with different BAs were determined by recording the OD₆₀₀ value when supplemented with 1 mM different BA species. The growth curves indicated that all BA compounds inhibited B. intestinalis growth to a different degree (Figure 2(a)). Compared to the controls, DCA and CDCA totally block the growth of B. intestinalis, while the impacts of LCA and TLCA were also significant as OD₆₀₀ values of B. intestinalis were almost half of that in each time point as compared to controls. In comparison, CA showed lowest inhibitory effect. Similar pattern of growth inhibition was observed in B. intestinalis incubated with T-BA, except TCDCA, a lower inhibition effect compared with CDCA. Notably, both DCA and TDCA at 1 mM can totally blocked the B. intestinalis growth. The colony count experiments supported the results of growth curve (Figures 2(b) and 2(c)).

(a)

(b)

(c)

3.2. Proteomic Characterization of B. intestinalis with Different Bile Acid Stimuli

A total of 28238 and 28693 unique peptide sequences were identified which mapped to 2567 and 2568 unique protein IDs from runs A and B, respectively. To ensure sound statistical analysis, 2378 unique proteins commonly identified from both runs A and B with at least 2 unique peptides were used for iTRAQ quantitation.

Clustering analysis of proteomic data suggested that there were apparent patterns of expression profile related to BA stimulus (Figure 3(a)). One major observation is that the TDCA and TCDCA inflicted more overall proteome perturbation than TCA and TLCA. In turn, there were more proteins differentially expressed in response to TDCA (263 up- and 480 downregulated) and TCDCA (349 up- and 518 downregulated) treatments in comparison to TCA (161 up- and 148 downregulated) and TLCA (78 up- and 126 downregulated) (Figure 3(b)). More importantly, both TDCA and TCDCA insults resulted in substantially more downregulated DEPs than upregulated ones, suggesting overall suppression roles of TDCA and TCDCA against multiple metabolic functions of B. intestinalis. The list of DEPs from all comparisons can be found in supplementary table 1.

(a)

(b)

Figure 3

Differentially expressed proteins (DEPs) selected by proteomics. Expression level of DEPs across samples was transformed into -score by rows and summarized in heatmap with -means-based clustering analysis performed both sample- and gene-wise (a). Shades of red or green represent elevation or decrease, respectively, of a protein expression level relative to the median levels in each row. Selection of DEPs based on differences (log2Ratio) and level of significance ( of -test) in BA vs. N comparisons (b). Red and green dots indicate up- and downregulated DEPs.

3.3. Proteomic Change of B. intestinalis Related to Bile Acid Toxicity

The clustering analysis helped to identify a set of DEPs with incremental changes in response to different levels of toxicities imposed by TCA, TLCA, TCDCA, and TDCA, respectively (Figure 4). The differential BA toxicity gradually upregulated 34 DEPs mainly related to genetic information processing and nucleotide metabolism and downregulated 77 DEPs mainly related to metabolism of carbohydrate, nucleotide, and amino acids according to BlastKOALA GO annotation analysis.

Since gut lumen BA pool is mainly comprised of secondary BA components (LCA and DCA), we then focused on the proteomic response against TDCA which is highly inhibitory for B. intestinalis and that against TLCA. Compared to TLCA treatment, TDCA upregulated 194 DEPs mainly related to genetic information processing and nucleotide metabolism and downregulated 243 DEPs mainly related to metabolism of carbohydrate, nucleotide, and amino acids according to BlastKOALA GO annotation analysis. This is generally in line with proteomic modulation by BA toxicity as we mentioned above. Table 1 summarizes key B. intestinalis DEPs in response to BA toxicity and also shows differential expression between TDCA and TLCA (, ). The list included multiple upregulated DEPs in transcription and translation and downregulated DEPs in energy metabolism.

3.4. Impact of BAs on Proteins Related to BA Metabolism

The expression of key B. intestinalis enzymes related to the bioconversion of BAs, the BSHs that deconjugate BAs and 7a-HSDH that produce secondary BAs, was investigated in this study (Figure 5(a)). The choloylglycine hydrolases (BSH, accession ID: B3CDZ0, B3CF59) showed little impact by TCA and TLCA stimuli, while TCDCA showed significant inhibitory effect for both choloylglycine hydrolases ( for B3CDZ0 and for B3CF59) and TDCA also showed mild inhibitory effect for choloylglycine hydrolase B3CF59. Besides, TCA, TCDCA, and TDCA showed mild inhibitory effect without statistical significance on the expression level of 7-alpha-hydroxysteroid dehydrogenase (hdhA, accession ID: B3CHT1).

(a)

(b)

(c)

3.5. Proteins Related to Polysaccharide and SCFA Metabolisms Are Suppressed by BAs

Like other Bacteroides members, B. intestinalis converts dietary polysaccharide, including xylans, to SCFAs which is critical to the health of gut mucosa. Our data shows that the BA toxicity, particularly of TCDCA and TDCA, can significantly suppress the enzyme systems that utilize polysaccharides, including glycosyl hydrolases (B3C9H7, B3C9W9, B3C8V4, B3C7I0, B3C9T6, B3CHU2, B3CA05, B3CEN8, B3C773, B3CIL1, B3CIL5, B3CG33, and B3CFB5) and SusD proteins (starch utilization system, B3C8X1, B3CIL3, B3CEP1, and B3CA46), xylanases (B3CHE1 and B3C594), and acetyl xylan esterase (B3CG29) (Figure 5(b)). Several key enzymes related to monosaccharide or oligosaccharide metabolism were also inhibited, such as arabinose isomerase (B3CG78), galactosidase (B3CC04), and cellobiose 2-epimerase (B3C6K4). Additionally, enzymes related to SCFA production, such as methylmalonyl-CoA epimerase (B3CEL4) and methylmalonyl-CoA mutase (B3C5T4), phosphate butyryltransferase (B3C7Y8), and acetate kinase (B3C6Z9), were all similarly inhibited by TCDCA and TDCA (Figure 5(c)).

4. Discussion

It is previously shown that BAs, as key determinant of gut microbiome, led to outgrowth of Firmicutes, Clostridia, and Erysipelotrichia species at the expense of Bacteroidetes [30]. This in vitro study confirmed the inhibitory effects of all major BA components on B. intestinalis, which is a common Bacteroidetes member present in human GI. Both CDCA and DCA showed much stronger inhibitory effects on B. intestinalis growth than CA and LCA. Our observation fits with the previous study which showed that Bacteroides were strongly suppressed by DCA [25]. Acting as detergent, BAs solubilize bacterial membrane lipids and destabilize membrane proteins, a process that eventually leads to cell lysis [26]. It is known that CDCA and DCA, both containing 2 hydroxyl groups in their perhydrocyclopentanophenanthrene steroid ring, have unique hydrophobic and detergent properties [4, 31]. Therefore, we believe that the stronger bactericidal effects of dihydroxy-BAs could explain our observation that CDCA and DCA, whether in free or conjugated forms, cause significant inhibition to the growth of B. intestinalis at physiological relevant concentration. In agreement with growth curve data, the more profound proteomic responses to TCA and TLCA treatments were clustered together, while less shifted proteome profile of TCDCA and TDCA treatments was clustered together (Figure 3(a)).

Interestingly, the most highlighted protein upregulated in response to BA toxicity is outer membrane efflux tolC (Table 1). The AcrAB-TolC complex was studied intensively as a critical stress and multidrug resistance gene in Gram-negative bacteria that pumps out a variety of antibiotics, detergents, lipids, dyes, and quorum sensing molecules [5, 32–34]. Future researches are needed to clarify the role of tolC efflux protein related to BA metabolism and transportation and to explore the impact of BA components on bacteria multidrug resistance mechanism. As a part of stress response, B. intestinalis apparently also enhanced genetic information processing and protein synthesis upon BA insults. The upregulations of multiple ribosomal subunits and protein chaperones are probably due to the high demand of proteome reconfiguration and to maintain DNA integrity during BA challenges. On the other hand, central metabolisms of carbohydrate and amino acids were otherwise compromised. These data were in line with the previous proteomic studies that showed BA challenges lead to significant alterations of energy metabolism and gene transcription/translation in Bifidobacterium longum, Lactobacillus reuteri, Lactobacillus johnsonii, Lactobacillus plantarum, and Lactobacillus salivarius [35–39]. Related to important metabolic functions of B. intestinalis, we have revealed the negative impact of BA toxicity on enzyme system of polysaccharide utilization, including that of starch, xylans (i.e., noncellulosic polysaccharides), and ligo-/monosaccharides. Interestingly, another proteomic study on Bacteroides fragilis also documented the suppression effect of BA on the starch utilization system (Sus) [40], which is critical for polysaccharide metabolism in Bacteroides [41]. Moreover, we found that genes related to SCFA production, a key function of GI Bacteroides, were also suppressed by BAs.

As a part of general metabolic inhibition of B. intestinalis by BA toxicity, we also noticed that enzyme system related to BA conversion was also affected. The expression level of BSH, which enzymatically liberates the free BAs from conjugated BAs, was dampened by TCDCA or TDCA. In contrary, there were reports showing that BA challenge in Lactobacillus johnsonii, Lactobacillus salivarius, and Lactobacillus plantarum can actually upregulate BSH expression [36, 38, 39]. Such discrepancies in regulation of BSH genes by BAs are probably microbial species specific or BA species or concentration dependent. Additionally, the expression of hdhA, which converts primary BAs to secondary counterparts, was also slightly inhibited by BA, which further explain the strong bactericidal effects particularly of CDCA and DCA on B. intestinalis. It is worthy to point out that unlike major producer of DCA such as Clostridium and Eubacterium [26], B. intestinalis instead produce ursodeoxycholic acid, 7-ketolithocholic acid, or 7-epi-cholic acid, which provide benefits to the host [3, 21, 23]. The previous study has shown that the 7-ketolithocholic acid produced by B. intestinalis can be considered as a biomarker of GI health, and lower level of this secondary BA was documented as an indicator of microbiome dysbiosis in patients with liver cirrhosis [42].

As complex proteomic response of B. intestinalis by different BA species was revealed, this study may provide insights to the interindividual variability in intestinal microflora composition possibly caused by the different BA composition. However, because treatment with individual BAs did not fully reflect the BA pressure on the bacteria in actual GI environment, future investigations were needed to clarify B. intestinalis functional modulation with dynamic BA metabolism in vivo.

5. Conclusion

This work unraveled differential proteomic impact of BAs with incremental toxicity against B. intestinalis. We confirmed the greater growth inhibitory effects of both TCDCA and TDCA on B. intestinalis and thus caused more differentially expressed proteins than TCA and TLCA. We further discovered that the main functional changes of B. intestinalis involved with enhanced protein synthesis and DNA integrity maintenance and suppressed central metabolic activities in response to incremental BA toxicity. The key BA metabolic enzymes including hdhA and BSHs were inhibited by TCDCA and TDCA.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors who have taken part in this study declared that they do not have anything to disclose regarding funding or conflict of interest with respect to this manuscript.

Acknowledgments

This work was supported by the National Natural Science Foundation of China (81702040), Research Project of Jinan Microecological Biomedicine Shandong Laboratory (JNL-2022030C and JNL-2022031C), and Provincial Foundation of the Science and Technology Department of Zhejiang Province (LGF19H200007). We also want to thank Dr. Ding Shi and Ms. Jing Jiang for the technical support.

Supplementary Materials

Supplemental material for this article may be found at SupplTable1 (the list of DEPs from all comparisons in this study). (Supplementary Materials)

References

A. F. Hofmann, J. Sjovall, G. Kurz et al., “A proposed nomenclature for bile acids,” Journal of Lipid Research, vol. 33, no. 4, pp. 599–604, 1992.
View at: Publisher Site | Google Scholar
I. A. Macdonald, V. D. Bokkenheuser, J. Winter, A. M. McLernon, and E. H. Mosbach, “Degradation of steroids in the human gut,” Journal of Lipid Research, vol. 24, no. 6, pp. 675–700, 1983.
View at: Publisher Site | Google Scholar
T. Eggert, D. Bakonyi, and W. Hummel, “Enzymatic routes for the synthesis of ursodeoxycholic acid,” Journal of Biotechnology, vol. 191, pp. 11–21, 2014.
View at: Publisher Site | Google Scholar
M. Watanabe, S. Fukiya, and A. Yokota, “Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents,” Journal of Lipid Research, vol. 58, no. 6, pp. 1143–1152, 2017.
View at: Publisher Site | Google Scholar
J. L. Ramos, E. Duque, M. T. Gallegos et al., “Mechanisms of solvent tolerance in Gram-negative bacteria,” Annual Review of Microbiology, vol. 56, no. 1, pp. 743–768, 2002.
View at: Publisher Site | Google Scholar
Human Microbiome Project C, “Structure, function and diversity of the healthy human microbiome,” Nature, vol. 486, no. 7402, pp. 207–214, 2012.
View at: Publisher Site | Google Scholar
C. Haro, S. Garcia-Carpintero, J. F. Alcala-Diaz et al., “The gut microbial community in metabolic syndrome patients is modified by diet,” The Journal of Nutritional Biochemistry, vol. 27, pp. 27–31, 2016.
View at: Publisher Site | Google Scholar
R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, “Human gut microbes associated with obesity,” Nature, vol. 444, no. 7122, pp. 1022-1023, 2006.
View at: Publisher Site | Google Scholar
R. Liu, J. Hong, X. Xu et al., “Gut microbiome and serum metabolome alterations in obesity and after weight- loss intervention,” Nature Medicine, vol. 23, no. 7, pp. 859–868, 2017.
View at: Publisher Site | Google Scholar
J. Y. Yang, Y. S. Lee, Y. Kim et al., “Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice,” Mucosal Immunology, vol. 10, no. 1, pp. 104–116, 2017.
View at: Publisher Site | Google Scholar
C. Chassard, V. Goumy, M. Leclerc, C. Del'homme, and A. Bernalier-Donadille, “Characterization of the xylan-degrading microbial community from human faeces,” FEMS Microbiology Ecology, vol. 61, no. 1, pp. 121–131, 2007.
View at: Publisher Site | Google Scholar
P. Y. Hong, M. Iakiviak, D. Dodd, M. Zhang, R. I. Mackie, and I. Cann, “Two new xylanases with different substrate specificities from the human gut bacterium Bacteroides intestinalis DSM 17393,” Applied and Environmental Microbiology, vol. 80, no. 7, pp. 2084–2093, 2014.
View at: Publisher Site | Google Scholar
K. Wang, G. V. Pereira, J. J. Cavalcante, M. Zhang, R. Mackie, and I. Cann, “Bacteroides intestinalis DSM 17393, a member of the human colonic microbiome, upregulates multiple endoxylanases during growth on xylan,” Scientific Reports, vol. 6, no. 1, p. 34360, 2016.
View at: Publisher Site | Google Scholar
M. Zhang, J. R. Chekan, D. Dodd et al., “Xylan utilization in human gut commensal bacteria is orchestrated by unique modular organization of polysaccharide-degrading enzymes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 35, pp. E3708–E3717, 2014.
View at: Publisher Site | Google Scholar
D. H. Chung, B. M. Evers, C. M. Townsend Jr., K. F. Huang, D. N. Herndon, and J. C. Thompson, “Role of polyamine biosynthesis during gut mucosal adaptation after burn injury,” American Journal of Surgery, vol. 165, no. 1, pp. 144–149, 1993.
View at: Publisher Site | Google Scholar
J. Timmons, E. T. Chang, J. Y. Wang, and J. N. Rao, “Polyamines and gut mucosal homeostasis,” Journal of Gastrointestinal & Digestive System, vol. 3, no. 1, 2013.
View at: Publisher Site | Google Scholar
E. Larque, M. Sabater-Molina, and S. Zamora, “Biological significance of dietary polyamines,” Nutrition, vol. 23, no. 1, pp. 87–95, 2007.
View at: Publisher Site | Google Scholar
A. Andoh, T. Tsujikawa, and Y. Fujiyama, “Role of dietary fiber and short-chain fatty acids in the colon,” Current Pharmaceutical Design, vol. 9, no. 4, pp. 347–358, 2003.
View at: Publisher Site | Google Scholar
J. B. Greer and S. J. O'Keefe, “Microbial induction of immunity, inflammation, and cancer,” Frontiers in Physiology, vol. 1, p. 168, 2011.
View at: Publisher Site | Google Scholar
W. Scheppach, “Effects of short chain fatty acids on gut morphology and function,” Gut, vol. 35, 1 Suppl, pp. S35–S38, 1994.
View at: Publisher Site | Google Scholar
S. Fukiya, M. Arata, H. Kawashima et al., “Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces,” FEMS Microbiology Letters, vol. 293, no. 2, pp. 263–270, 2009.
View at: Publisher Site | Google Scholar
B. V. Jones, M. Begley, C. Hill, C. G. Gahan, and J. R. Marchesi, “Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 36, pp. 13580–13585, 2008.
View at: Publisher Site | Google Scholar
S. Tawthep, S. Fukiya, J. Y. Lee et al., “Isolation of six novel 7-oxo- or urso-type secondary bile acid-producing bacteria from rat cecal contents,” Journal of Bioscience and Bioengineering, vol. 124, no. 5, pp. 514–522, 2017.
View at: Publisher Site | Google Scholar
H. Bernstein, C. Bernstein, C. M. Payne, K. Dvorakova, and H. Garewal, “Bile acids as carcinogens in human gastrointestinal cancers,” Mutation Research, vol. 589, no. 1, pp. 47–65, 2005.
View at: Publisher Site | Google Scholar
A. S. Devlin and M. A. Fischbach, “A biosynthetic pathway for a prominent class of microbiota-derived bile acids,” Nature Chemical Biology, vol. 11, no. 9, pp. 685–690, 2015.
View at: Publisher Site | Google Scholar
M. Begley, C. G. Gahan, and C. Hill, “The interaction between bacteria and bile,” FEMS Microbiology Reviews, vol. 29, no. 4, pp. 625–651, 2005.
View at: Publisher Site | Google Scholar
J. P. Hamilton, G. Xie, J. P. Raufman et al., “Human cecal bile acids: concentration and spectrum,” American Journal of Physiology. Gastrointestinal and Liver Physiology, vol. 293, no. 1, pp. G256–G263, 2007.
View at: Publisher Site | Google Scholar
L. Ning, G. Shan, Z. Sun et al., “Quantitative proteomic analysis reveals the deregulation of nicotinamide adenine dinucleotide metabolism and CD38 in inflammatory bowel disease,” BioMed Research International, vol. 2019, Article ID 3950628, 11 pages, 2019.
View at: Publisher Site | Google Scholar
M. Kanehisa, Y. Sato, and K. Morishima, “BlastKOALA and GhostKOALA: KEGG tools for functional characterization of genome and metagenome sequences,” Journal of Molecular Biology, vol. 428, no. 4, pp. 726–731, 2016.
View at: Publisher Site | Google Scholar
K. B. Islam, S. Fukiya, M. Hagio et al., “Bile acid is a host factor that regulates the composition of the cecal microbiota in rats,” Gastroenterology, vol. 141, no. 5, pp. 1773–1781, 2011.
View at: Publisher Site | Google Scholar
J. P. Grill, C. Cayuela, J. M. Antoine, and F. Schneider, “Isolation and characterization of a Lactobacillus amylovorus mutant depleted in conjugated bile salt hydrolase activity: relation between activity and bile salt resistance,” Journal of Applied Microbiology, vol. 89, no. 4, pp. 553–563, 2000.
View at: Publisher Site | Google Scholar
H. Nikaido and Y. Takatsuka, “Mechanisms of RND multidrug efflux pumps,” Biochimica et Biophysica Acta, vol. 1794, no. 5, pp. 769–781, 2009.
View at: Publisher Site | Google Scholar
H. Venter, R. Mowla, T. Ohene-Agyei, and S. Ma, “RND-type drug efflux pumps from gram-negative bacteria: molecular mechanism and inhibition,” Frontiers in Microbiology, vol. 6, p. 377, 2015.
View at: Publisher Site | Google Scholar
L. J. Piddock, “Multidrug-resistance efflux pumps - not just for resistance,” Nature Reviews Microbiology, vol. 4, no. 8, pp. 629–636, 2006.
View at: Publisher Site | Google Scholar
B. Sanchez, M. C. Champomier-Verges, P. Anglade et al., “Proteomic analysis of global changes in protein expression during bile salt exposure of Bifidobacterium longum NCIMB 8809,” Journal of Bacteriology, vol. 187, no. 16, pp. 5799–5808, 2005.
View at: Publisher Site | Google Scholar
L. X. Lv, R. Yan, H. Y. Shi et al., “Integrated transcriptomic and proteomic analysis of the bile stress response in probiotic Lactobacillus salivarius LI01,” Journal of Proteomics, vol. 150, pp. 216–229, 2017.
View at: Publisher Site | Google Scholar
K. Lee, H. G. Lee, and Y. J. Choi, “Proteomic analysis of the effect of bile salts on the intestinal and probiotic bacterium Lactobacillus reuteri,” Journal of Biotechnology, vol. 137, no. 1-4, pp. 14–19, 2008.
View at: Publisher Site | Google Scholar
J. Y. Lee, E. A. Pajarillo, M. J. Kim, J. P. Chae, and D. K. Kang, “Proteomic and transcriptional analysis of Lactobacillus johnsonii PF01 during bile salt exposure by iTRAQ shotgun proteomics and quantitative RT-PCR,” Journal of Proteome Research, vol. 12, no. 1, pp. 432–443, 2013.
View at: Publisher Site | Google Scholar
E. Hamon, P. Horvatovich, E. Izquierdo et al., “Comparative proteomic analysis of Lactobacillus plantarum for the identification of key proteins in bile tolerance,” BMC Microbiology, vol. 11, no. 1, p. 63, 2011.
View at: Publisher Site | Google Scholar
R. F. Boente, H. Pauer, D. N. Silva et al., “Differential proteomic analysis of outer membrane enriched extracts of Bacteroides fragilis grown under bile salts stress,” Anaerobe, vol. 39, pp. 84–90, 2016.
View at: Publisher Site | Google Scholar
K. H. Cho and A. A. Salyers, “Biochemical analysis of interactions between outer membrane proteins that contribute to starch utilization by Bacteroides thetaiotaomicron,” Journal of Bacteriology, vol. 183, no. 24, pp. 7224–7230, 2001.
View at: Publisher Site | Google Scholar
H. J. Huang, A. Y. Zhang, H. C. Cao et al., “Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients,” Digestive and Liver Disease, vol. 45, no. 8, pp. 677–682, 2013.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2023 Zeyu Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies